Literature DB >> 16376824

Significance of release technology in tissue engineering.

Yasuhiko Tabata1.   

Abstract

Regenerative medical therapy has been expected to compensate for the therapeutic disadvantages of reconstructive surgery and organ transplantation, as well as offering a new therapeutic strategy. The objective of regenerative medical therapy is to induce the repair of defective tissues based on the natural healing potential of patients. For successful tissue regeneration, it is indispensable to provide cells with a local environment of artificial extracellular matrix where they can proliferate and differentiate efficiently. Tissue engineering is the key to this regeneration environment; release technology often enhances the in vivo stability of growth factors and related genes and prolongs the maintenance of biological functions for tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376824     DOI: 10.1016/S1359-6446(05)03639-1

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  16 in total

Review 1.  Tooth regeneration: implications for the use of bioengineered organs in first-wave organ replacement.

Authors:  Taka Nakahara; Yoshiaki Ide
Journal:  Hum Cell       Date:  2007-08       Impact factor: 4.174

2.  Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: tuning of protein release kinetics.

Authors:  Marco Biondi; Laura Indolfi; Francesca Ungaro; Fabiana Quaglia; Maria Immacolata La Rotonda; Paolo A Netti
Journal:  J Mater Sci Mater Med       Date:  2009-05-18       Impact factor: 3.896

Review 3.  Biomaterial technology for tissue engineering applications.

Authors:  Yasuhiko Tabata
Journal:  J R Soc Interface       Date:  2009-03-04       Impact factor: 4.118

4.  Laser Doppler imaging evaluation of adipogenesis after adipose tissue-derived stem cell implantation.

Authors:  Ran Ito; Naoki Morimoto; Shigehiko Suzuki
Journal:  J Artif Organs       Date:  2013-06-22       Impact factor: 1.731

5.  Alginate-crosslinked chitosan scaffolds as pentoxifylline delivery carriers.

Authors:  Hsin-Yi Lin; Chih-Tsung Yeh
Journal:  J Mater Sci Mater Med       Date:  2010-02-27       Impact factor: 3.896

6.  Cell-laden microengineered gelatin methacrylate hydrogels.

Authors:  Jason W Nichol; Sandeep T Koshy; Hojae Bae; Chang M Hwang; Seda Yamanlar; Ali Khademhosseini
Journal:  Biomaterials       Date:  2010-04-24       Impact factor: 12.479

7.  Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery.

Authors:  Fa-ming Chen; Zhi-wei Ma; Guang-ying Dong; Zhi-fen Wu
Journal:  Acta Pharmacol Sin       Date:  2009-03-23       Impact factor: 6.150

8.  A novel method for the preparation of retinoic acid-loaded nanoparticles.

Authors:  Cesare Errico; Matteo Gazzarri; Federica Chiellini
Journal:  Int J Mol Sci       Date:  2009-05-19       Impact factor: 6.208

9.  Aldehyded Dextran and ε -Poly(L-lysine) Hydrogel as Nonviral Gene Carrier.

Authors:  Yumiko Togo; Katsu Takahashi; Kazuyuki Saito; Honoka Kiso; Boyen Huang; Hiroko Tsukamoto; Suong-Hyu Hyon; Kazuhisa Bessho
Journal:  Stem Cells Int       Date:  2013-08-21       Impact factor: 5.443

Review 10.  Drug releasing systems in cardiovascular tissue engineering.

Authors:  Cristiano Spadaccio; Massimo Chello; Marcella Trombetta; Alberto Rainer; Yoshiya Toyoda; Jorge A Genovese
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.